GGrantIndex
← Leaderboards

Isabelle Caroline Le Poole

Loyola University Chicago

$8,988,921
Attributed
$9,880,198
Total exposure
13
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,880,198 · 13

By mechanism

R01$7,977,941 · 6
P30$1,179,557 · 3
R03$370,500 · 2
R56$332,200 · 1
R13$20,000 · 1

Top collaborators

Others in their field

Top investigators on “Cells

Research focus

CellsImmuneSkinAntigensImmune ResponseMelanomaResponseVitiligoMouse ModelEnvironmentT-LymphocyteIn VivoAntibodiesPigmentsAutoimmune ProcessAutoimmune ResponsesTissuesAffectMelanocyteMonitorBaseDendritic CellsIn VitroDesign

Grant awards (36)

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM$593,023
R01 · FY2025 · HL · contact PI
Mechanisms of Lymphomagenesis of Skin Resident Gamma Delta T cells$496,574
R01 · FY2025 · CA · contact PI
Core C-Test IT$116,052
P30 · FY2025 · AR · contact PI
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM$584,415
R01 · FY2024 · HL · contact PI
Core C-Test IT$132,485
P30 · FY2024 · AR · contact PI
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM$605,116
R01 · FY2023 · HL · contact PI
Core C TEST IT$172,524
P30 · FY2023 · AR · contact PI
Core C TEST IT$180,908
P30 · FY2022 · AR · contact PI
Core C TEST IT$185,429
P30 · FY2021 · AR · contact PI
Core C TEST IT$191,275
P30 · FY2020 · AR · contact PI
Separating autoimmunity and anti-tumor immunity$349,910
R01 · FY2019 · CA · contact PI
Core C TEST IT$200,884
P30 · FY2019 · AR · contact PI
Separating autoimmunity and anti-tumor immunity$366,573
R01 · FY2018 · CA · contact PI
Separating autoimmunity and anti-tumor immunity$369,101
R01 · FY2017 · CA · contact PI
Separating autoimmunity and anti-tumor immunity$345,413
R01 · FY2016 · CA · contact PI
Separating autoimmunity and anti-tumor immunity$345,413
R01 · FY2015 · CA · contact PI
Targeting HSP70 in autoimmune vitiligo$332,200
R56 · FY2014 · AR · contact PI
Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo$314,768
R01 · FY2014 · AR · contact PI
Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo$305,132
R01 · FY2013 · AR · contact PI
Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo$321,192
R01 · FY2012 · AR · contact PI
Targeting HSP70 in autoimmune vitiligo$314,566
R01 · FY2012 · AR · contact PI
Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo$321,192
R01 · FY2011 · AR · contact PI
Targeting HSP70 in autoimmune vitiligo$314,447
R01 · FY2011 · AR · contact PI
Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo$345,713
R01 · FY2010 · AR · contact PI
Targeting HSP70 in autoimmune vitiligo$327,429
R01 · FY2010 · AR · contact PI
Targeting HSP70 in autoimmune vitiligo$330,618
R01 · FY2009 · AR · contact PI
Targeting HSP70 in autoimmune vitiligo$341,128
R01 · FY2008 · AR · contact PI
Chemopreventive treatment of familial melanoma$74,250
R03 · FY2008 · CA · contact PI
Autoimmune vitiligo as a roadmap to melanoma therapy$222,472
R01 · FY2007 · CA · contact PI
Chemopreventive treatment of familial melanoma$74,250
R03 · FY2007 · CA · contact PI
Pigmentation and Diversity Conference$20,000
R13 · FY2007 · AR · contact PI
Autoimmune vitiligo as a roadmap to melanoma therapy$229,116
R01 · FY2006 · CA · contact PI
Autoimmune vitiligo as a roadmap to melanoma therapy$234,630
R01 · FY2005 · CA
Stress proteins in autoimmune depigmentation$74,000
R03 · FY2005 · AR
Stress proteins in autoimmune depigmentation$74,000
R03 · FY2004 · AR
Stress proteins in autoimmune depigmentation$74,000
R03 · FY2003 · AR